Pharma Supply Chains in the Crossfire
May 5, 2026
How tariff uncertainty and geopolitical tensions are reshaping pharmaceutical logistics
6 min read
False
Advertisement
Small Molecules
What Sponsors Get Wrong When Initiating an Oncology Study
By Luke Gill, Claudio Hegenberger
May 4, 2026
How CRO selection significantly influences study outcomes
6 min read
Trends and Challenges in Nitrosamine Testing: Part Five – Pharma’s Future
May 1, 2026
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
3 min read
Trends and Challenges in Nitrosamine Testing: Part Three – Building a Method
April 24, 2026
Following part two, which explored the analytical challenges involved in nitrosamine testing, our experts return to offer their top tips for building a method from scratch
4 min read
The Secrets of the Gut
April 20, 2026
Going beyond the gut: why microbiome testing is the next big thing in drug development
3 min read
Trends and Challenges in Nitrosamine Testing Part Four The Regulatory Landscape
April 17, 2026
Following part two, which explored the analytical challenges involved in nitrosamine testing, our experts return to offer their top tips for building a method from scratch
2 min read
Navigating Formulation Change in the EU
By Matthew Weinberg
April 15, 2026
How to turn regulatory complexity into strategic strength
7 min read
Trends and Challenges in Nitrosamine Testing: Part One – Scoping the Problem
April 3, 2026
In the first part of a new analytical science-focused series about all things nitrosamines, five experts share their first experiences, understanding of the danger, and comparisons with other industries
Precision Therapies: The Last Mile
By Pete Harbin
March 12, 2026
Why therapies still take years to reach the patients who need them
4 min read
Study Explores Liver Outcomes After HIV Treatment Switch
March 5, 2026
PASO DOBLE sub-analysis reports steatosis differences at 96 weeks
1 min read
